Attention Deficit Hyperactivity Disorder (ADHD) News and Research RSS Feed - Attention Deficit Hyperactivity Disorder (ADHD) News and Research Twitter

Attention deficit-hyperactivity disorder (ADHD) is a neurobehavioral disorder that affects 3-5 percent of all American children. It interferes with a person's ability to stay on a task and to exercise age-appropriate inhibition (cognitive alone or both cognitive and behavioral). Some of the warning signs of ADHD include failure to listen to instructions, inability to organize oneself and school work, fidgeting with hands and feet, talking too much, leaving projects, chores and homework unfinished, and having trouble paying attention to and responding to details. There are several types of ADHD: a predominantly inattentive subtype, a predominantly hyperactive-impulsive subtype, and a combined subtype. ADHD is usually diagnosed in childhood, although the condition can continue into the adult years.
Shire receives FDA guidance on regulatory path for investigational compound SHP 465

Shire receives FDA guidance on regulatory path for investigational compound SHP 465

Shire plc today announced that it has received further guidance from the U.S. Food and Drug Administration on the regulatory path for SHP 465 (triple-bead mixed amphetamine salts MAS), an investigational oral stimulant medication being evaluated as a potential treatment for Attention-Deficit/Hyperactivity Disorder (ADHD) in adults. [More]
Brain & Behavior Research Foundation to honor 8 scientists for achievements in psychiatric research

Brain & Behavior Research Foundation to honor 8 scientists for achievements in psychiatric research

The Brain & Behavior Research Foundation will honor eight scientists with its 2014 Outstanding Achievement Prizes for work delving into psychiatric disorders that affect one in four people. The awards, which celebrate the transformative power of neuroscience and psychiatric research to improve the lives of people with mental illness, will be presented at the Foundation's National Awards Dinner at the Pierre Hotel. [More]
Stimulation therapy and behavioral management training for parents reduce kids’ violent behaviors

Stimulation therapy and behavioral management training for parents reduce kids’ violent behaviors

Prescribing both a stimulant and an antipsychotic drug to children with physical aggression and attention-deficit/hyperactivity disorder (ADHD), along with teaching parents to use behavior management techniques, reduces aggressive and serious behavioral problems in children, according to a study conducted by researchers in the Department of Psychiatry at Stony Brook University School of Medicine. [More]
Genetics may underpin psychiatric comorbidity in bipolar patients

Genetics may underpin psychiatric comorbidity in bipolar patients

Relatives of people with bipolar disorder are at an increased risk of developing not only bipolarity but also other psychiatric disorders, according to Swedish researchers. [More]
Drinking before pregnancy can increase risk of behavioural problems in toddlers

Drinking before pregnancy can increase risk of behavioural problems in toddlers

Risk drinking before pregnancy can increase the risk of the development behavioural problems in toddlers. [More]
Pediatrician currently utilizes Quotient ADHD test on patients

Pediatrician currently utilizes Quotient ADHD test on patients

Attention Deficit Hyperactivity Disorder (ADHD) is a common childhood condition characterized by more than normal difficulty with focus, behavior control, impulsivity and hyperactivity. [More]
Study explores how changes in dopamine transporter function linked to brain disorders

Study explores how changes in dopamine transporter function linked to brain disorders

Recent published research in the Journal of Clinical Investigation demonstrates how changes in dopamine signaling and dopamine transporter function are linked to neurological and psychiatric diseases, including early-onset Parkinsonism and attention deficit hyperactivity disorder (ADHD). [More]
Use ADHD questionnaire ‘with caution’ in bipolar patients

Use ADHD questionnaire ‘with caution’ in bipolar patients

A questionnaire used to determine whether or not someone has attention-deficit hyperactivity disorder should be used with caution in patients with bipolar disorder, Swiss researchers suggest. [More]
Validity of DSM-5 change to age of onset criterion for diagnosis of ADHD

Validity of DSM-5 change to age of onset criterion for diagnosis of ADHD

A recent study published in the July 2014 issue of the Journal of the American Academy of Child and Adolescent Psychiatry confirms the validity of the DSM-5 change to the age of onset criterion for diagnosis of attention-deficit/hyperactivity disorder (ADHD). [More]
NIH funds Phase II 90-subject pediatric clinical trial at UCLA

NIH funds Phase II 90-subject pediatric clinical trial at UCLA

NeuroSigma, Inc., a California-based life sciences company focused on commercialization of its non-invasive Monarch eTNS System for the treatment of neurological and neuropsychiatric disorders, today announced that the U.S. National Institutes of Health (NIH) has awarded UCLA a grant that funds a Phase II 90-subject pediatric clinical trial at the University of California, Los Angeles focused on the treatment of Attention Deficit Hyperactivity Disorder (ADHD) with NeuroSigma's external trigeminal nerve stimulation (eTNS) System. [More]
Higher risk of psychiatric disorders found in children born to women with fertility problems

Higher risk of psychiatric disorders found in children born to women with fertility problems

Children born to women with fertility problems have a higher risk of psychiatric disorders than naturally conceived children. The increase in risk was described as "modest" by researchers from Denmark, but was found to persist throughout childhood and into young adulthood. [More]
Psychostimulant increases risk of cardiovascular events in children with ADHD

Psychostimulant increases risk of cardiovascular events in children with ADHD

Psychostimulant use to treat children and adolescents with attention-deficit/hyperactivity disorder (ADHD) is increasing worldwide, and the evaluation of the cardiovascular safety of stimulant medication used in treatment has been a recent topic of concern. [More]
Brain iron levels offer potential biomarker in the diagnosis of ADHD

Brain iron levels offer potential biomarker in the diagnosis of ADHD

Brain iron levels offer a potential biomarker in the diagnosis of attention deficit hyperactivity disorder (ADHD) and may help physicians and parents make better informed treatment decisions, according to new research published online in the journal Radiology. [More]
Researchers uncover several gene networks with potentially important roles in autism

Researchers uncover several gene networks with potentially important roles in autism

A large new analysis of DNA from thousands of patients has uncovered several underlying gene networks with potentially important roles in autism. [More]
Gene networks may offer attractive targets for developing new autism drugs

Gene networks may offer attractive targets for developing new autism drugs

A large new analysis of DNA from thousands of patients has uncovered several underlying gene networks with potentially important roles in autism. [More]
Neuroscientists explain how miswiring in brain area can potentially contribute to ADHD

Neuroscientists explain how miswiring in brain area can potentially contribute to ADHD

Neuroscientists at Mayo Clinic in Florida and at Aarhus University in Denmark have shed light on why neurons in the brain's reward system can be miswired, potentially contributing to disorders such as attention deficit hyperactivity disorder (ADHD). [More]
BabySafe Project offers 10 steps to help pregnant women limit wireless radiation exposure

BabySafe Project offers 10 steps to help pregnant women limit wireless radiation exposure

An international group of doctors and scientific experts is joining with non-profit organizations today to urge pregnant women to limit their exposure to wireless radiation from cell phones and other devices by taking simple steps to protect themselves and their unborn children. [More]
10,000 toddlers receive medication for ADHD, shows report

10,000 toddlers receive medication for ADHD, shows report

"It does not surprise me that some children are being given medicine as the easy way out but that doesn't mean it's the right way to do it," says Max Wiznitzer, MD, a pediatric neurologist at University Hospitals Rainbow Babies & Children's Hospitals about the Center for Disease Control's estimate 10,000 toddlers receive medication for attention-deficit/hyperactivity disorder (ADHD). [More]
Actavis reaches agreement to continue supplying authorized generic version of JPI's Concerta

Actavis reaches agreement to continue supplying authorized generic version of JPI's Concerta

Actavis plc today announced that it has reached an agreement with Janssen Pharmaceuticals, Inc. to continue supplying the authorized generic version of JPI's Concerta (methylphenidate hydrochloride extended-release tablets). [More]
Johns Hopkins scientists identify genetic marker associated with development of obsessive-compulsive disorder

Johns Hopkins scientists identify genetic marker associated with development of obsessive-compulsive disorder

A group of researchers led by Johns Hopkins scientists say they have identified a genetic marker that may be associated with the development of obsessive-compulsive disorder (OCD), whose causes and mechanisms are among the least understood among mental illnesses. [More]
Advertisement
Advertisement